A B S T R A C T This study was undertaken to de-termine what factors control the conversion of thyroxine (T4) to triiodothyronine (T3) in rat liver under conditions approximating those found in vivo. Conversion of T4 to T3 was studied in the isolated perfused rat liver, a preparation in which the cellular and structural integrity is maintained and that can perform most of the physiologic functions of the liver. The perfused liver readily extracted T4 from perfusion medium and converted it to T3. Production of T3 by the perfused liver was a function of the size of the liver, the uptake of T4 by the liver, and the presence of T4-5'-deiodinase activity. Production of T3 was increased by increasing the uptake of T4 by liver, which could be accomplished by increasing the liver size, by increasing the perfusate T4 concentration, or by decreasing the perfusate albumin concentration. These changes occurred without altering the conversion of T4 to T3. The liver had a large capacity for extracting T4 and for T4-5'-deiodination to T3, which was not saturated at a T4 concentration of 60 ,ug/dl. Production of T3 was decreased by inhibiting hepatic T4-5'-deiodinase with propylthiouracil, which decreased T3 production by decreasing the conversion of T4 to T3. Propylthiouracil did not alter hepatic T4 uptake.
A B S T R A C T This study was undertaken to de- termine what factors control the conversion of thyroxine (T4) to triiodothyronine (T3) in rat liver under conditions approximating those found in vivo. Conversion of T4 to T3 was studied in the isolated perfused rat liver, a preparation in which the cellular and structural integrity is maintained and that can perform most of the physiologic functions of the liver. The perfused liver readily extracted T4 from perfusion medium and converted it to T3. Production of T3 by the perfused liver was a function of the size of the liver, the uptake of T4 by the liver, and the presence of T4-5'-deiodinase activity. Production of T3 was increased by increasing the uptake of T4 by liver, which could be accomplished by increasing the liver size, by increasing the perfusate T4 concentration, or by decreasing the perfusate albumin concentration. These changes occurred without altering the conversion of T4 to T3. The liver had a large capacity for extracting T4 and for T4-5'-deiodination to T3, which was not saturated at a T4 concentration of 60 ,ug/dl. Production of T3 was decreased by inhibiting hepatic T4-5'-deiodinase with propylthiouracil, which decreased T3 production by decreasing the conversion of T4 to T3. Propylthiouracil did not alter hepatic T4 uptake.
Fasting resulted in a progressive decrease in hepatic T4 uptake to 42% of control levels by the 3rd d of fasting; this was accompanied by a proportionate decrease in T3 production. The rate of conversion of T4 to T3 did not change during fasting. When T4 uptake in 2-d-fasted rat livers was raised to levels found in fed rats by increasing the perfusate T4 concentration from 10 to 30 ,g/dl, T3 production retumed to normal. Again, no change in the rate of conversion of T4 to T3 was observed.
INTRODUCTION
Many tissues are known to deiodinate thyroxine (T4)l with the resultant production of 3,5,3'-triiodothyroxine (T3) (1) (2) (3) (4) (5) (6) (7) (8) (9) , but only recently has it been appreciated that most ofthe circulating T3 is derived from extrathyroidal 5'-monodeiodination of T4 rather than from thyroidal secretion (10) (11) (12) (13) . This deiodination increases the metabolic effect of T4 because T3 is more potent than T4. Additional studies have shown that T4 can also undergo 5-monodeiodination in extrathyroidal tissues with the formation of 3,3',5'-triiodothyronine (rT3) (14, 15) ; this mechanism accounts for nearly all ofthe daily rT3 production. Unlike T3, rT3 has little intrinsic metabolic activity, though it inhibits the conversion of T4 to T3 in vitro (16, 17) .
These alternate pathways of T4 metabolism provide a mechanism whereby the metabolic effects of T4 can be regulated by decreasing the availability of T3 to tissues. That such regulation occurs is suggested by the findings of decreased serum T3 concentrations in humans during starvation, acute and chronic illness, in the fetus, and in response to several pharmacologic agents (18, 19) . Kinetic studies in fasted or cirrhotic patients directly demonstrated decreased peripheral conversion of T4 to T3 (15, 20) . However, the elevated serum rT3 concentrations were found to result primarily from decreased rT3 degradation rather than from increased rT3 production. In vitro studies using rat liver homogenates and slices have shown that fasting is asso-ciated with decreased generation of T3 from T4 (17, 21, 22) and decreased rT3 degradation (17) and have suggested that decreased T4-5'-deiodinase activity was responsible for these changes. Although it is clear that hepatic T4-5'-deiodinase activity is decreased in fasted rats, it is not clear whether the liver produces less T3 from T4 during fasting or, if it does, that decreased deiodinase activity is responsible for decreased T3 production under physiologic conditions in vivo. This study was undertaken to determine what factors control the production of T3 from T4 using the isolated perfused liver, a preparation in which cellular and structural integrity are preserved, and that is capable of performing most of the physiologic functions of the liver.
METHODS
Materials. T3, T4, bovine serum albumin (BSA), propylthiouracil (PTU), and methimazole (MMI) were purchased from Sigma Chemical Co., St. Louis, Mo. The T3 and T4 used in perfusions were dissolved in 0.01 N NaOH (100 jig/ml) and stored at -200C.
[125I]T3 and [125I]T4 were prepared by iodination of 3,5-T2 and T3, respectively, using previously described techniques (23) . Iobead resin was purchased from Technicon Instruments Corp., Tarrytown, N. Y.
Animals. Male Sprague-Dawley rats weighing 250-300 g were used in all experiments. The animals were fed Wayne Lab-Blox rat feed (Allied Mills, Inc., Chicago, Ill.) and had free access to tap water. In each study, rats from one shipment were used and the mean animal weight for each group was comparable. In the fasting studies, each group of rats was matched for weight before the initiation of fasting. Fasting was begun at 9 a.m. and the perfusions performed between 9 a.m. and 1 p.m. To study the effect of PTU in vivo, rats were given PTU as a 0.05%-solution in 25% glucose (to enhance its palatability) for 3 d in place of drinking water. As a control, another group of rats was given 25% glucose for 3 d in place of drinking water.
Technique of rat liver perfusion. A modification of the method of Exton and Park (24, 25) was used for isolation and perfusion of the rat liver in situ. After induction of anesthesia with intraperitoneal sodium pentobarbital (60 mg/kg) (Abbott Laboratories, North Chicago, Ill.), the abdomen was opened and ligatures placed around the inferior vena cava above the right renal vein, the superior mesenteric and celiac arteries, and the portal vein. A cannula was rapidly inserted into the portal vein and the perfusion pump started. The vena cava below the right renal vein was then cut, allowing perfusion medium to flow through the liver and escape; the ligatures around the portal vein and the arteries were tied. The thorax was then opened and an outflow cannula inserted through the right atrium into the thoracic vena cava. Finally, the ligature around the abdominal inferior vena cava was tied, thus closing the circuit. The perfusate leaving the liver flowed by gravity to a reservoir 15-20 cm below the liver and was subsequently recirculated. The livers contained little endogenous blood by the time the circuit was completed because, when perfused with buffer containing no BSA or erythrocytes, the livers lost all color and the perfusate leaving the liver contained few erythrocytes (<5,000/mm3) and little protein (<0.1 mg/ml). Livers were perfused for 1-2 h and in any study the perfusion duration was identical in all animals (see figure legends for exact perfusion times).
The perfusion medium consisted of Krebs-Henseleit bicarbonate buffer (KHBB) containing BSA (3 g/dl except when otherwise stated) and sufficient outdated human erythrocytes to give a hematocrit of 12-16%. The BSA was initially prepared as a 25 g/dl solution in KHBB, which was dialyzed for 48 h at 4°C against three to four changes of KHBB. The erythrocytes were washed twice with 2-3 vol of both 0.9% NaCl and KHBB before use. Because leukocytes are reported to concentrate amino acids (26) and to convert T4 to T3 and rT3 (27) , the leukocyte layer was carefully aspirated with each washing. Unless otherwise stated, the T4 and glucose concentrations were 10 ,ug/dl and 100 mg/dl, respectively. The medium (95 ml) was equilibrated in the apparatus with 95% 02-5% CO2 before perfusion to achieve a temperature of 37°C and a pH of 7.4. The final volume in the system when the circuit was complete was 56-58 ml, and care was taken to keep the final volume as constant as possible from perfusion to perfusion.
Using this technique the preparation was routinely completed within 4-6 min after opening the abdomen, and at no time was the liver unperfused. For the duration of the perfusion, livers from fed rats appeared grossly normal and maintained a normal oxygen consumption and bile production (2.31±0. 20 [SEM] ,tmol/min perg liver, n = 8; 49.3+1.1 .ul/h per g liver, n = 8). No liver swelling occurred during the perfusion as evidenced by an unchanged wet to dry weight ratio (perfused, 2.25+0.05, n = 9; unperfused, 2.23±0.04, n = 8) and liver weight to body weight ratio (perfused, 3.92±0.09 g/100 g, n = 8; unperfused, 3.98±0.06 g/100 g, n = 8). The metabolic normalcy of the preparation was evidenced by attainment of maximal rates of gluconeogenesis from lactate (20 mM), 96±5 ,umol/g per h, n = 7, during the first 15 min of perfusion in 48-h-fasted rats (24) .
Samples (1 ml) were taken from the reservoir every 30 min and kept on ice until separation of the erythrocytes. The medium was stored at -20°C until assayed. At the end of the perfusion, the pump was stopped, and a 0.6-0.9-g portion of liver was rapidly placed in a preweighted grinding vessel containing 1 ml 0.01 M P04, 0.15 M NaCl, pH 7.4, at 4°C. The grinding vessel was quickly reweighed and then stored at -700C until further processing. The perfusion medium was then pumped out of the apparatus and its volume determined. The sum ofthis volume, the volume ofthe samples removed during the perfusion, and the residual volume, i.e., the volume remaining in the apparatus after evacuation, -0.5 ml, was taken as the initial volume in the recirculating system. The remaining liver was removed and weighed, thus allowing calculation of the total liver weight.
Processing of liver samples. The liver samples were thawed to 40C and then homogenized with a motor driven Teflon (Dupont Instrument Corp., Wilmington, Del.) pestle. The homogenate was twice extracted with 4 ml 100% ethanol and the extracts pooled. The pooled extract was stored at -20°C for [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] h to allow further precipitation of liver tissue, recentrifuged, the final volume recorded, and an aliquot stored at -20°C for assay. Using this method, [125I]T3 was extracted with an efficiency that was inversely proportional to the liver weight according to the following equation: extraction efficiency (%) = -21.6 x liver weight (g) + 91.9 (r = 0.96, P < 0.001).
The final T3 concentration in the liver extracts was corrected for the extraction efficiency obtained using this formula. The extraction efficiency of T4 was not influenced by the weight ofthe liver sample and averaged 58.93±0.53%. The efficiency of extraction of T3 and T4 was unaffected by fasting.
T3 and T4 determinations in perfusion media. Samples were assayed in quadruplicate using double antibody radioConversion of Thyroxine to Triiodothyronine in Rat Liver immunoassay methods previously described for serum (28, 29) . The T3 assay conditions were identical to the serum assay with the following exceptions: (a) use of [125I]T3 of a high specific activity (23); (b) dilution of anti-T3 antibody to a final dilution of 1:15,000; and (c) preparation of the standard curve with KHBB and the appropriate concentration of BSA. The sensitivity of this assay was 4-8 pg T3/tube. The perfusate T4 assay was identical to the serum assay except the standards were prepared with KHBB and BSA. Assay sensitivity was 20 pg/tube. Deiodination of [125I]T3 was determined using lobeads, an ion exchange resin that removes inorganic iodide from aqueous solutions.
T3 and T4 determinations in liver extracts. These determinations were carried out in quadruplicate using double antibody radioimmunoassay techniques as previously described (17) . The sensitivity of the assays was 4-8 pg/tube for T3 and 20-40 pg/tube for T4. Varying the volume of liver extract from 10 to 100 ,ul resulted in linear dose-response curves.
Calculations. The uptake of T4 by the liver was calculated by the following formulas: (a) T4 uptake = (initial T4 concentration -final concentration) x mean corrected perfusion volume; (b) mean corrected perfusion volume = final volume -[erythrocyte volume + 0.5 (sample volume removed during perfusion)].
The appearance of T3 in the perfusion medium was calculated as follows: (c) T3 appearance (perfusate) = (final T3 concentration -initial T3 concentration) x mean corrected perfuision volume.
The appearance of T3 in the liver was calculated by subtracting, from the observed liver T3 concentration, the mean liver T3 concentration in a comparable group of rats following perfusion with medium containing no T4 and multiplying this difference by the total liver weight. Perfusion with medium containing no T4 did not alter the endogenous liver T3 concentration in either fed or fasted rats. Thus, T3 production was calculated as the sum of the perfusate and liver productions. This does not take into account any biliary secretion of T3 and its conjugates or deiodination of T3 by liver (see Results). The conversion of T4 to T3 was calculated by dividing the T3 production by the T4 taken up by the liver.
Expression of results. The uptake of T4 and the production of T3 are expressed relative to the wet weight of the liver in grams except when an experimental manipulation resulted in a change in liver size between groups, i.e., fed vs. fasted animals (see Results, Fig. 6 ). When such comparisons were made, T4 uptake and T3 production were then expressed as the absolute quantity in micrograms or nanograms, respectively.
Statistical evaluation of data. In experiments with two groups of animals, statistical analysis was performed using Student's t test. When three or more treatment groups were studied, a one-way analysis of variance was performed and Duncan's multiple range test was then applied to identify significant differences among specific groups (30) . Data are presented as the mean+SEM.
RESULTS
General characteristics of the perfusion system (Fig. 1) . When perfused at a T4 concentration of 10 ,ug/dl, a BSA concentration of 4%, and a flow rate of 1.5 ml/g liver per min, the rat liver readily extracted T4 from the media as evidenced by a significant decline in the perfusion medium T4 concentration by 30 min (P < 0.001). Though the T4 concentration continued to~i 10- Corresponding points in the lower two panels represent the mean+SEM of eight perfusions of the indicated duration.
fall during the course of the perfusion, this decline was minimal and subsequent T4 concentrations were not significantly lower than the 30-min value. The extraction of T4 by the liver was associated with a prompt, significant increase in both the perfusate T3 concentration (P < 0.001) and the liver T3 concentration (P < 0.001) by 30 (Table I) . When livers were perfused at different flow rates based on the average liver wt/100 g body wt, T3 production was maximal at flow rates of 1.0-1.5 ml/g liver per min. When perfused at 3 ml/g liver per minute, T3 production was significantly lower (P < 0.05). The hepatic extraction of T4 was unaffected by these varia'tions in flow rate. All subsequent studies were performed using a flow rate of 1.5 ml/g liver per min.
Effect of perfusate glucose concentration (Table II) . Varying the glucose concentration from 0 to 300 mg/dl had no effect on T3 production at an initial perfusate T4 concentration of either 10 or 30 ,ug/dl. Similarly, T3 production by livers from fasted rats was the same at medium glucose concentrations of 40, 100, and 300 mg/dl. The addition of insulin to perfusion medium containing 100 or 300 mg/dl glucose had no effect on T3 production by livers from either fed or fasted rats.
Effect 12 .0+ 1.3% (n = 4) in fed rats and 11.7 +0.8% (n = 4) in fasted rats. Neither the biliary excretion nor the deiodination of T3 were used in calculating T3 production in the system and therefore the reported values underestimate the true production. However, it is clear that differences in biliary excretion or deiodination cannot explain any difference between fed and fasted rats.
Effect of liver weight (Fig. 2) . When livers of fed rats were perfused at a T4 concentration of 10 ,ug/dl and a BSA concentration of 3 g/dl, large rat livers (12.65±+0.75 g) took up more T4 (P <0.02) and produced more T3 (P <0.05) than did small rat livers (7.65±0.52 g). Both T4 uptake and T3 production were Perfusion medium contained 4 g/dl BSA and 10 i.g/dl T4.
Perfusions were of 2 h duration. (Fig. 3) . Increasing the perfusate T4 concentration from 3 to 60 ,ug/dl, at a BSA concentration of 4 g/dl, resulted in a progressive increase in T4 uptake by the liver (P < 0.001 for 30 and 60 ug/dl vs. 3 and 10 ug/dl). This increase in T4 uptake was associated with an increased T3 production (P < 0.005 and < 0.001 for 30 and 60 ,ug/dl vs. 3 and 10ug/dl). No differences in the percent conversion of T4 to T3 were found as the T4 concentration was increased, again indicating that a relatively constant fraction of the extracted T4 was converted to T3. Even with a perfusate T4 concentration of 60 ,ugldl, the maximal response may not have been obtained. It is important to note that at T4 concentrations similar to those found in the rat, i.e., [3] [4] [5] [6] [7] [8] [9] [10] ,ug/dl, the slope of the dose response was shallow and an increase in the perfusate T4 concentration was not associated by a proportionate increase in either T4 uptake or T3 production. Effects of the perfusate BSA concentration (Fig. 4) . Increasing the perfusate BSA concentration from 1 to 4 g/dl, at a T4 concentration of 10 ug/dI, resulted in a progressive stepwise reduction in the uptake of T4 by the liver (P < 0.001 for 3 and 4 g/dl vs. 1 g/dl). This reduction in T4 uptake was associated with a concomitant reduction in T3 production (P < 0.05 for 3 and 4 g/dl vs. 1 gIdl). No difference in the percent conversion of T4 to T3 was observed as the BSA concentration was increased, indicating that the quantity ofT3 produced was directly proportional to the quantity of T4 taken up by the liver.
Effects of PTU and MMI (Fig. 5) . Because PTU is an inhibitor of T4-5'-deiodinase activity in homogenate systems (16, 17) , perfusion with PTU should inhibit T3 production by decreasing the percent conversion of T4 to T3. When livers of fed rats were perfused with media containing PTU (58.7 ,uM), a significant reduction in both T3 production (P < 0.001) and the percent conversion of T4 to T3 (P < 0.001) was found. Likewise, when PTU was given to rats as a 0.05% solution in 25% glucose, a significant reduction in both T3 production (P < 0.001) and percent conversion of T4 to T3 (P < 0.001) was found when compared with rats given only 25% glucose. Addition of MMI (87.7 ,uM) to perfusion media had no effect on T3 production.
Effects of fasting (Fig. 6) . Fasting for 1-3 d was Effect of perfusate T4 concentration on T4 uptake and T3 production in fasting (Fig. 7) . If decreased uptake of T4 is the primary defect responsible for decreased hepatic T3 production in fasting, then in- creasing T4 uptake to levels found in fed rats should return T3 production to normal. When the perfusate T4 concentration was increased from 10 to 30 Zg/dl in 2-d fasted rats (3 g/dl BSA), T4 uptake increased progressively to levels found in fed rats. T3 production was restored to normal when the perfusate T4 concentration was 30 A.g/dl. The rate of conversion of T4 to T3 did not change over this range of T4 concentrations.
However, when livers of 2-d fasted rats were perfused at 100 ,ug/dl, the conversion of T4 to T3 fell from 3.93±0.66 to 2.19+0.25% (P < 0.05). These data indicate that the decline in conversion of T4 to T3 observed in homogenate preparations in fasted rats can be reproduced in the perfused liver at high, unphysiologic T, concentrations. However, at more physiologic T4 concentrations, this phenomenon is not observed.
Effects of fasting on the endogenous liver T3 and T4 content (Fig. 8) . Fasting was associated with a decrease in the hepatic content of both T3 and T4 which was statistically significant after 1 ports the contention that the fall in hepatic deiodinase activity observed during fasting is not the primary regulatory mechanism for decreasing the hepatic production of T3 from T4 because if it were, a decrease in the hepatic ratio ofT3 to T4 should have been found.
DISCUSSION The present studies demonstrate the utility of the perfused rat liver for studying hepatic T3 production. The results show that three factors are important in determining hepatic T3 production: liver size; T4 uptake by the liver; and hepatic T4-5'-deiodinase activity. The liver was found to have a large capacity for both T4 uptake and T4-5'-deiodination, which was not saturated at high, unphysiologic T4 concentrations. Finally, the results show that hepatic production of T3 from T4 was decreased during fasting and provide evidence that at physiologic concentrations of T4, the decline in T3 production resulted primarily from decreased hepatic T4 uptake rather than from changes in the rate of conversion of T4 to T3, i.e., in T4-5'-deiodinase activity.
Previous studies using rat liver homogenates and slices have clearly demonstrated a decrease in T4-5'-deiodinase activity during fasting (17, 21, 22) , untreated streptozotocin-induced diabetes (21), hypothyroidism (22, (31) (32) (33) , and in the fetus (34, 35) . This decrease in 5'-deiodinase activity in fasting has been attributed wholly or in part to deficiency of a cytosol cofactor rather than to a quantitative decrease in the enzyme itself (36) (37) (38) . Substances that maintain sulfhydryl groups in the reduced state, such as reduced glutathione, NADPH, and dithiothreitol were shown to restore T4-5'-deiodinase activity to normal levels in liver homogenates from fasted rats. In contrast, agents that oxidize sulfhydryl groups, such as diamide, oxidized gluthathione, mercuric chloride, and Nethylmaleimide, produced a decrease in homogenate deiodinase activity. More recently, PTU, an allosteric inhibitor of deiodinase activity (16, 17) , was shown to compete with reduced glutathione for a noncatalytic site on the deiodinase enzyme (39) . Taken together, these data have suggested that hepatic 5'-deiodinase activity is modulated by altering the availability of reduced sulfbydryl groups, presumably glutathione.
Although these studies have shed considerable light on the biochemistry of T4-5'-deiodination, it is not clear whether the decrease in deiodinase activity is the primary regulatory mechanism mediating the decreased conversion of T4 to T3 under physiologic conditions. The data cited above were obtained primarily from in vitro studies using rat liver homogenates. Such broken cell preparations lack both the control systems associated with intact cellular and organ structure and the ability to respond to metabolic and hormonal perturbations. The incubations were performed in buffer solutions containing little or no binding proteins, with inadequate or absent oxygenation, and using high concentrations of T4 ,ug/dl). In such preparations homogenate deiodinase activity had a Km for T4 of 1.5-7.7 ,uM (116. 5-592.9 ,ug/dl) (17, 34) , a priori suggesting lack of a regulatory role because the enzymatic capacity greatly exceeds the quantities of endogenous T4 available for deiodination. Thus, the 50% reduction in deiodinase activity found in liver homogenates from fasted rats should have little measurable effect on the conversion of T4 to T3 at physiologic T4 concentrations. Finally, homogenate preparations, although allowing study of the enzymatic and biochemical aspects of deiodination, cannot be used to evaluate the possibility that T3 neogenesis, like gluconeogenesis, might be regulated by the availability of substrate, i.e., T4, as well as by the prevailing enzyme activity.
Use of the isolated perfused liver obviates some of the above-mentioned problems. The cellular and structural integrity of the liver is maintained in a milieu similar to that of the intact rat. The ability to respond to both substrate and hormonal signals was maintained, and the T4 concentration (10 ,ug/dl) used was close to that found in the normal rat (3) (4) (5) ,ug/dl), although the percentage of protein-bound T4 would be lower. The isolated perfused liver readily extracted T4 from the perfusion media and 5'-deiodinated it with the production of T3, in accord with previous studies with this preparation (40) . The ,ug/dl, far exceeding that ever found -in vivo. In contrast, PTU decreased T3 production by reducing the percent conversion of T4 to T3, as would be expected of an inhibitor of T4-5'-deiodinase, without altering T4 uptake. These perfusion results indicate that the primary factor responsible for the decreased hepatic T3 production observed during fasting was decreased T4 uptake. When rats were fasted for 1-3 d, hepatic T4 uptake decreased in proportion to the fall in liver weight. Decreased T4 uptake was accompanied by a proportionate decrease in T3 production. There was no change in the conversion of T4 to T3. Furthermore, when T4 uptake by livers from fasted rats was increased to levels found in livers from fed rats, by increasing the perfusate T4 concentration from 10 to 30 uLgldl, total T3 production was restored to normal. Again, there was no change in the rate of conversion of T4 to T3. Only at a very high T4 concentration (100 ,g/dl) was the conversion of T4 to T3 decreased during fasting. Therefore, at physiologic T4 concentrations, the 50-60% decrease in T4-5'-deiodinase activity in liver homogenates from fasted rats probably does not play a major regulatory role in decreasing hepatic T3 production during fasting, consistent with the kinetic measurements in homogenates indicating a high Km (high capacity) enzyme. The concomitant and proportionate fall in the endogenous liver T4 and T3 content during fasting further supports the validity of the in vitro findings.
It is important to appreciate that the perfusate-free T4 concentration was higher than that found in normal rat serum because the only T4-binding protein present was albumin, a high capacity, low affinity T4-binding protein (T3-resin uptake 35 .9% for rat serum, 47 .5% for 4.0% BSA) and because the T4 concentration (10 ,ug/dl) was two-to three-fold greater than that in normal rat serum (3-5 ,ug/dl) . This was evidenced by the finding that perfusion with a T4 concentration of 10 ,ug/dl and BSA concentration of 4 g/dl increased the liver T4 concentration to 8-10 times above the endogenous T4 concentration. The perfused liver was therefore driven to produce more T3 than usually occurs in vivo because of the increased hepatic uptake of T4. In the presence of additional and more potent T4-binding proteins, as are present in serum, T4 uptake by the liver would be less, limiting to a greater extent the T4 available for conversion of T3. Therefore, under in vivo conditions, the uptake of T4 into the liver would be even more rate limiting for the conversion of T4 to T3 than was apparent in the perfused liver.
Although these studies underscore the importance of the T4 uptake into the liver as a regulatory mechanism for T3 production, altered conversion of T4 to T3 (altered enzyme activity) is also important. This is the mechanism by which PTU inhibits T3 production. Preliminary studies in situations of extreme metabolic abnormality, i.e., untreated streptozotocin-induced diabetes, indicate that decreased T3 production is a result of both decreased T4 uptake and decreased conversion of T4 to T3 (deiodinase activity). Furthermore, the methods used in the present study may not be sufficiently sensitive to detect small changes in conversion of T4 to T3.
Decreased hepatic uptake of T4 during fasting could result from either decreased activity of a specific transport system for T4, decreased quantities of tissue T4-binding proteins, or increased serum concentration of a compound(s) that competed with T4 for either transport sites or T4-binding proteins. Although there is little evidence to support the existence of a specific T4 transport system, there is considerable evidence that hepatic T4 uptake is influenced by the quantity and the affinity of T4-binding proteins on each side ofthe plasma membrane (41) (42) (43) (44) (45) . The studies reported here demonstrating decreased T4 uptake into the liver with increasing perfusate albumin concentrations provide further validation for this concept. It seems likely that the decreased T4 uptake in fasted rat livers resulted from a decrease in T4-binding proteins in the liver. A number of cellular proteins have binding sites for T4. These proteins are located in a variety of cell fractions including the nucleus (46, 47) , mitochondria (48, 49) , microsomes (50) , cytosol (51, 52) , and plasma membranes (53, 54) . Recent evidence suggests that the binding capacity of both the hepatocyte nucleus (55) (56) (57) and cytosol (58) for thyroid hormones is reduced by fasting. Which of the cellular T4-binding proteins is most important in regulating the uptake of T4 into the cell and the mechanisms through which these binding sites are regulated remain to be determined.
In summary, the data demonstrate the utility of the isolated perfused liver in the study of T4 metabolism. The results demonstrate the large capacity of the liver for T4 uptake and its 5'-deiodination to T3. Hepatic production of T, from T4 was decreased by fasting; this decrease primarily resulted from decreased T4 uptake by the liver. The data further suggest, though they do not prove, that the uptake of T4 into the liver is determined by the relative abundance of cellular and extracellular T4 binding sites and that the decreased hepatic uptake of T4 during fasting resulted from loss of cellular T4-binding proteins.
